| 1 |
Sandvik AB
SAND · ST
|
$48B |
79/100
Strong
|
44/100 |
16.8%low 12.6% |
10 yr+ |
0.3× |
40% |
Sandvik AB: A Record 22.6% Margin With SEK 550 Million of Tungsten Inside It, and No Margin of Safety at SEK 368.70Aug 21, 2026 · Hold |
FY2025 |
| 2 |
Novartis AG
NOVN · SW
|
$306B |
78/100
Strong
|
46/100 |
20.9%low 9.0% |
10 yr+ |
0.6× |
71% |
Novartis (NVS) Zen Horizon Research ReportJun 8, 2026 · Hold |
FY2025 |
| 3 |
Rio Tinto PLC
RIO · LSE
|
$148B |
78/100
Strong
|
38/100 |
22.4%low 11.8% |
10 yr+ |
0.2× |
61% |
Rio Tinto: Copper EBITDA Rose 84% on 1% More Production, and £73.74 Sits Inside a £62–82 Hold BandSep 14, 2026 · Hold |
FY2025 |
| 4 |
Swisscom AG
SCMN · SW
|
$41B |
78/100
Strong
|
37/100 |
16.8%low 10.4% |
10 yr+ |
0.2× |
80% |
Swisscom AG: A 4.25% Dividend, a Finite Italian Synergy Bridge, and No Margin of Safety at CHF 635Aug 20, 2026 · Hold |
FY2025 |
| 5 |
Next PLC
NXT · LSE
|
$22B |
78/100
Strong
|
43/100 |
55.5%low 43.4% |
10 yr+ |
1.0× |
40% |
NEXT plc: 23.9% International Growth, a £16.9 Million Platform, and 19.2 Times EarningsAug 30, 2026 · Hold |
FY2026 |
| 6 |
Jeronimo Martins SGPS SA
JMT · LS
|
$12B |
78/100
Strong
|
42/100 |
22.6%low 15.5% |
10 yr+ |
— |
21% |
Jerónimo Martins: EBITDA Up 7.6%, Net Profit Down 3.5%, and No Conservative Margin of SafetyAug 31, 2026 · Hold |
FY2025 |
| 7 |
ABB Ltd
ABBN · SW
|
$183B |
77/100
Strong
|
46/100 |
21.9%low 8.1% |
10 yr+ |
0.2× |
33% |
ABB Ltd: 58% Electrification Order Growth, and a 19.5x EBITDA Test of Capital DisciplineAug 11, 2026 · Hold |
FY2025 |
| 8 |
Thales S.A.
HO · Paris
|
$55B |
77/100
Strong
|
46/100 |
16.8%low 9.5% |
10 yr+ |
0.2× |
25% |
Thales: A Genuine Defence-Electronics Quality Compounder, Priced Like the Best Case Is Already Locked InJul 7, 2026 · Hold |
FY2025 |
| 9 |
Bunzl PLC
BNZL · LSE
|
$11B |
76/100
Strong
|
39/100 |
19.3%low 16.5% |
10 yr+ |
0.8× |
20% |
Bunzl: 0.4% Underlying Growth, 237 Acquisitions, and 15.6 Times EarningsAug 29, 2026 · Hold |
FY2025 |
| 10 |
Eckert & Ziegler Strahlen- und Medizintechnik AG
EUZ · XETRA
|
$1.0B |
76/100
Strong
|
44/100 |
14.4%low 9.1% |
10 yr+ |
Net cash |
48% |
Eckert & Ziegler SE: A Better Business, Not Yet a Better PriceJul 15, 2026 · Hold |
FY2025 |
| 11 |
Deutsche Post AG
DHL · XETRA
|
$70B |
75/100
Strong
|
38/100 |
19.6%low 14.0% |
10 yr+ |
0.9× |
11% |
DHL AG: Express Supplies 60% of H1 Group EBIT on 31% of Revenue and German Mail Volume Falls 15%, but EUR 55.02 Sits 30% Above the EUR 42.2 Conservative ValueSep 14, 2026 · Hold |
FY2025 |
| 12 |
Intertek Group PLC
ITRK · LSE
|
$11B |
75/100
Strong
|
45/100 |
30.4%low 22.5% |
10 yr+ |
1.2× |
32% |
Intertek: Quality Compounder on a Takeover BidJun 17, 2026 · Hold |
FY2025 |
| 13 |
Orkla ASA
ORK · OL
|
$11B |
75/100
Strong
|
35/100 |
14.3%low 9.8% |
10 yr+ |
0.3× |
50% |
Orkla: Zero Organic Growth in the Controlled Portfolio, Jotun Operating Profit Up 21%, and a 21% NAV Discount at NOK 97.10Aug 25, 2026 · Hold |
FY2025 |
| 14 |
Alfa Laval AB
ALFA · ST
|
$25B |
74/100
Strong
|
47/100 |
15.9%low 11.4% |
10 yr+ |
0.3× |
34% |
Alfa Laval: A 35% Order Surge, a 2% Profit Increase, and 29 Times EarningsAug 27, 2026 · Hold |
FY2025 |
| 15 |
SGS SA
SGSN · SW
|
$24B |
74/100
Strong
|
44/100 |
48.5%low 30.6% |
10 yr+ |
3.3× |
48% |
SGS: High-Quality TIC Compounder at Full ValueJun 17, 2026 · Hold |
FY2025 |
| 16 |
Skanska AB (publ)
SKA-B · ST
|
$12B |
74/100
Strong
|
38/100 |
15.3%low 8.9% |
10 yr+ |
Net cash |
9% |
Skanska AB: A Record SEK 297.5bn Backlog Rests on a 4.3% Contractor Margin, and SEK 271.90 Leaves No Conservative Margin of SafetySep 5, 2026 · Hold |
FY2025 |
| 17 |
JD Sports Fashion PLC
JD · LSE
|
$5.4B |
74/100
Strong
|
37/100 |
20.6%low 6.7% |
10 yr+ |
0.9× |
48% |
JD Sports Fashion plc: Cheap Cash Flow, Falling Like-for-Like Sales, and the Cost of ControlSep 2, 2026 · Watch |
FY2026 |
| 18 |
Prosus N.V.
PRX · Amsterdam
|
$92B |
72/100
Strong
|
46/100 |
23.9%low 13.0% |
10 yr+ |
0.1× |
37% |
Prosus N.V.: A 38.4% NAV Discount, a Tencent-Funded Buyback, and No Conservative Margin of SafetyAug 20, 2026 · Hold |
FY2026 |
| 19 |
ACS Actividades de Construccion y Servicios SA
ACS · MC
|
$32B |
72/100
Strong
|
44/100 |
20.8%low 12.0% |
10 yr+ |
0.4× |
30% |
ACS Equity Research: Construction Scale, AI Infrastructure, and the Cost of a Re-ratingAug 21, 2026 · Hold |
FY2025 |
| 20 |
UCB SA
UCB · BR
|
$45B |
71/100
Strong
|
50/100 |
10.2%low 3.8% |
10 yr+ |
Net cash |
71% |
UCB SA: A Specialty-Biopharma Growth Platform That Has Already Re-RatedJun 29, 2026 · Hold |
FY2025 |
| 21 |
Bureau Veritas SA
BVI · Paris
|
$13B |
70/100
Strong
|
47/100 |
27.2%low 10.1% |
10 yr+ |
1.0× |
30% |
Bureau Veritas: Quality TIC, Priced for ReaccelerationJun 17, 2026 · Hold |
FY2025 |
| 22 |
Valmet Oyj
VALMT · HE
|
$5.2B |
70/100
Strong
|
41/100 |
15.0%low 9.3% |
10 yr+ |
0.3× |
24% |
Valmet Oyj: Two Businesses, One Share Price, and a Separation Thesis Already Partly PricedSep 2, 2026 · Hold |
FY2025 |
| 23 |
Schneider Electric S.E.
SU · Paris
|
$176B |
68/100
Strong
|
45/100 |
12.5%low 8.5% |
10 yr+ |
0.6× |
40% |
Schneider Electric (SU.PA) Zen Horizon Research ReportJun 5, 2026 · Watch |
FY2025 |
| 24 |
H & M Hennes & Mauritz AB (publ)
HM-B · ST
|
$30B |
68/100
Strong
|
32/100 |
20.2%low 2.3% |
10 yr+ |
2.4× |
52% |
H&M: The Margin Repair Is Real, the Growth Engine Is Not, and 23.8x Leaves No CushionAug 20, 2026 · Hold |
FY2025 |
| 25 |
Compagnie Financière Richemont SA
CFR · SW
|
$143B |
67/100
Strong
|
48/100 |
9.6%low 1.7% |
10 yr+ |
Net cash |
64% |
Compagnie Financière Richemont SA: Jewellery Earns EUR 5.04bn of Operating Profit While Watchmakers Earn EUR 107m, and CHF 183.65 Sits 18% Above the Conservative ValueSep 9, 2026 · Hold |
FY2026 |
| 26 |
ASM International NV
ASM · Amsterdam
|
$42B |
67/100
Strong
|
45/100 |
16.8%low 6.7% |
10 yr+ |
Net cash |
47% |
ASM International Deep Value Investment AnalysisJun 4, 2026 · Watch |
FY2025 |
| 27 |
Hexagon AB (publ)
HEXA-B · ST
|
$25B |
67/100
Strong
|
50/100 |
10.6%low 6.0% |
10 yr+ |
0.3× |
64% |
Hexagon AB (HEXA-B.ST) Zen Horizon Deep-Dive Research ReportJun 9, 2026 · Watch |
FY2025 |
| 28 |
SCHOTT Pharma AG & Co. KGaA
1SXP · XETRA
|
$2.9B |
67/100
Strong
|
35/100 |
20.6%low 16.4% |
6 yr |
— |
35% |
SCHOTT Pharma: A GLP-1 Boom Priced by the Dose, Not the Drug, and a Capacity Bill That Has Yet to Prove Its ReturnAug 6, 2026 · Hold |
FY2025 |
| 29 |
Danone SA
BN · Paris
|
$47B |
66/100
Strong
|
40/100 |
11.2%low 5.4% |
10 yr+ |
0.5× |
49% |
Danone: 55% of Profit in One Category, a Shrinking Chinese Birth Cohort, and Why 17.3x Leaves No Margin of SafetyAug 20, 2026 · Hold |
FY2025 |